Peter Shields MD

Peter Shields MD
ProfessorCollege of Medicineshields.167@osu.edu
519 James Cancer Hosp & Res Inst 300 W 10th Avenue Columbus Ohio 43210
Phone:614-688-6563Fax:
  • Cancer Control
  • Administrative

Research Description

Peter Shields, MD, deputy director of The Ohio State University Comprehensive Cancer Center (OSUCCC), is an internationally renowned physician-scientist and expert in cancer prevention. Recently named the president of the American Society of Preventive Oncology, Shields is a leader in researching new biomarkers of cancer risk, molecular epidemiology and carcinogenesis. His primary focus is identifying biomarkers that can be used in the clinic to assess breast and lung cancer risk, particularly those related to diet, smoking and lifestyle. He has published more than 180 studies in scientific journals on topics ranging from toxicology and epidemiology to behavior and health disparities. As deputy director, Shields oversees the OSUCCC’s research infrastructure and programs, which include more than 280 cancer researchers from 11 of Ohio State’s 14 colleges. He establishes university wide collaborations that translate basic research discoveries into cancer prevention and treatment strategies. Shields has much experience in developing research programs, having received several large multi-investigator grants and contracts. He also has developed education and research partnerships with minority-serving institutions that focus on cancer-related health disparities.

Current Publications

  • Higgins MJGenome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.Oncotarget 5 237-48 1/1/2014
  • Tao MH, Hainaut P, Marian C, Nie J, Ambrosone C, Edge SB, Trevisan M, Dorn J, Shields PG, Freudenheim JLAssociation of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status.Cancer Causes Control 24 2177-86 12/1/2013
  • Brasky TM, Li Y, Jaworowicz DJ Jr, Potischman N, Ambrosone CB, Hutson AD, Nie J, Shields PG, Trevisan M, Rudra CB, Edge SB, Freudenheim JLPregnancy-related characteristics and breast cancer risk.Cancer Causes Control 24(9) 1675-85 9/1/2013
  • Graves KD, Leventhal KG, Nusbaum R, Salehizadeh Y, Hooker GW, Peshkin BN, Butrick M, Tuong W, Mathew J, Goerlitz D, Fishman MB, Shields P, Schwartz MDBehavioral and psychosocial responses to genomic testing for colorectal cancer risk.Genomics 102(2) 123-30 8/1/2013
  • Ricks-Santi LJ, Nie J, Marian C, Ochs-Balcom HM, Trevisan M, Edge SB, Freudenheim JL, Shields PBRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.Genet Epidemiol 37(5) 504-11 7/1/2013
  • Llanos AA, Brasky TM, Dumitrescu RG, Marian C, Makambi KH, Kallakury BV, Spear SL, Perry DJ, Convit RJ, Platek ME, Adams-Campbell LL, Freudenheim JL, Shields PGPlasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women.Breast Cancer Res Treat 138(2) 571-9 4/1/2013
  • Luta G, Ford MB, Bondy M, Shields P, Stamey JDBayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data.Cancer Epidemiol 37(2) 121-6 4/1/2013
  • Han D, Nie J, Bonner MR, Ambrosone C, Marian C, Shields P, Trevisan M, Edge SB, Freudenheim JLClustering of place of birth for women with breast cancer: differences by tumor characteristics.Cancer Causes Control 24(3) 587-94 3/1/2013
  • Nusbaum R, Leventhal KG, Hooker GW, Peshkin BN, Butrick M, Salehizadeh Y, Tuong W, Eggly S, Mathew J, Goerlitz D, Shields P, Schwartz MD, Graves KDTranslational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.Transl Behav Med 3(1) 17-29 3/1/2013
  • Hsu PC, Zhou B, Zhao Y, Ressom HW, Cheema AK, Pickworth W, Shields PFeasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS.J Proteome Res 12(2) 679-91 2/1/2013
  • Llanos AA, Dumitrescu RG, Marian C, Makambi KH, Spear SL, Kallakury BV, Perry DJ, Convit RJ, Platek ME, Millen AE, Adams-Campbell LL, Freudenheim JL, Shields PAdipokines in plasma and breast tissues: associations with breast cancer risk factors.Cancer Epidemiol Biomarkers Prev 21(10) 1745-55 10/1/2012
  • Llanos AA, Makambi KH, Tucker CA, Wallington SF, Shields P, Adams-Campbell LLCholesterol, lipoproteins, and breast cancer risk in African American women.Ethn Dis 22(3) 281-7 6/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu